Clearsense has filed a notice of an exempt offering of securities to raise $20,322,495.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Clearsense is raising up to $20,322,495.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Jason Rose played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Clearsense
Clearsense is a scalable data platform for healthcare that enables real-time insights into clinical, operational and financial metrics. Convert your data into a single source of truth to accelerate data maturity, optimize analytics tools, improve decision quality and unlock meaningful outcomes. In one end to end platform, Clearsense integrates your data from any source, maintains line of sight from source to target, jumpstarts ROI in your existing Business Intelligence (BI) tools and unlocks value for clinical, operations, financial and research stakeholders without the need to hire specialized staff.
To learn more about Clearsense, visit http://clearsense.com/
Contact:
Jason Rose, Chief Executive Officer
904-364-5629
https://www.linkedin.com/in/jasonrose1/
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.